Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
78.69
-4.38 (-5.27%)
At close: Jan 17, 2025, 4:00 PM
78.90
+0.21 (0.27%)
After-hours: Jan 17, 2025, 7:54 PM EST

Novo Nordisk Revenue

Novo Nordisk had revenue of 71.31B DKK in the quarter ending September 30, 2024, with 21.42% growth. This brings the company's revenue in the last twelve months to 270.58B, up 26.15% year-over-year. In the year 2023, Novo Nordisk had annual revenue of 232.26B with 31.26% growth.

Revenue (ttm)
270.58B DKK
Revenue Growth
+26.15%
P/S Ratio
n/a
Revenue / Employee
4,206,891 DKK
Employees
64,319
Market Cap
352.70B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019122.02B10.19B9.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 393.90B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

NVO News

More News